The government’s Antivirals Taskforce has procured more antivirals per population than any other country in Europe, with over […]
Category: COVID-19
Brophy’s editorial on Merck’s Move-Out trial of molnupiravir raises important concerns about the approval of molnupiravir to treat […]
Using a different covid-19 vaccine for the third “booster” dose than was used for the initial two doses […]
The NHS has relaxed infection prevention and control (IPC) requirements for hospitals and GP practices that were introduced […]
Covid-19 cases in the US rose by 43% over the past two weeks, with especially high rates seen […]
The prevalence of sexually transmitted diseases (STDs) and deaths from drug overdoses increased in the US over the […]
In late November 2021, after weeks of no confirmed community transmission of SARS-CoV-2, Taiwan’s Central Epidemic Command Center […]
What is molnupiravir?Molnupiravir (marketed as Lagevrio) is an antiviral drug, slightly modified from a compound known as NHC […]
Hospitals and ambulance services in England are facing “extreme pressures” and a high volume of staff absences, forcing […]